Quest Laboratories Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Quest

CMP

135.45

+7.70 (6.03%)

  • DRHP
₹97

Offer Price

₹ 43.16 Cr

Issue Size

₹ 1,16,400

Min Investment

1,200

Lot size

Time Line

  • 15
    May 2024
    Open
  • 17
    May 2024
    Close
  • 21
    May 2024
    Finalisation of Basis of Allotment
  • 22
    May 2024
    Initiation of Refunds
  • 22
    May 2024
    Transfer of Shares to Demat Account
  • 23
    May 2024
    Listing Date

Objects of the Offer

  • Expansion and upgradation of its manufacturing facility.

  • Expand its Geographical Presence.

  • Widen its product portfolio.

  • Continue to improve operating efficiencies through technology enhancements.

Products & Services

  • Quest Laboratories Limited is engaged in the business of manufacturing of pharmaceutical formulations.

Strengths

  • Multi-product capability.

  • Revenue from Government institutions.

  • Product Portfolio.

  • Research and Development.

  • Quality assurance.

Risks

  • The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.

  • Any manufacturing or quality control problems may disrupt its business operations, damage the company reputation for high quality production and expose it to potential litigation or other liabilities, which would negatively impact its business, prospects, cash flows, results of operations and financial condition.

  • The Company is reliant on the demand from the pharmaceutical industry for a significant portion of its revenue. Any downturn in the pharmaceutical industry or an inability to increase or effectively manage its sales could have an adverse impact on the Company`s business and results of operations.

  • The products that the company commercialize may not perform as expected which could adversely affect its business, financial condition and results of operations.

  • Any manufacturing or quality control problems may damage its reputation for high quality products and expose the company to litigation or other liabilities, which could adversely affect its financial results.

Company Promoters

Promoters Holding

Issue For IPO
24.06%
Pre Holding

88.58%

Post Holding

64.52%

Top Promoters Holding

Financials

All values in Cr

Mar-2022 Mar-2023 Mar-2023 3-Yr trend
Revenue 59.48 (95.90%) 61.64 (3.60%) 33.47 (-)
Gross Profit 59.48 (95.90%) 61.64 (3.60%) 33.47 (-)
Net Income 59.48 (95.90%) 61.64 (3.60%) 33.47 (-)
Assets 59.48 (95.90%) 61.64 (3.60%) 33.47 (-)
Liabilities 59.48 (95.90%) 61.64 (3.60%) 33.47 (-)

Peers

Company Name Revenue (Cr) Net Profit (Cr) Assets (Cr) Liabilities (Cr) ROE EPS BVPS Current Ratio Debt to Assets
Quest Laboratories Ltd 61.64 5.03 19.20 4.18 33.47 0.00 139.25 1.31 0.21
Beta Drugs Ltd 227.11 30.72 198.42 198.42 24.99 31.95 127.82 15.48 0.13
Alpa Laboratories Ltd 92.96 12.58 167.27 167.27 9.34 5.88 63.96 7.52 0.02
Zenith Drugs Ltd 114.52 5.15 97.94 97.94 29.88 128.82 431.47 5.26 1.51

Book Running Managers

  • Shreni Shares Ltd

Registrar & Transfer Agent

Bigshare Services Pvt Ltd

Office No 56-2,
Pinnacle Busine.Park,
Mahakali Caves Road - Mumbai - 400093
Phone : 91-22-62638200 Fax: 91-22-63638299

Company Contact Information

Plot # 45 Sector III,
Pithampur,
Dhar - 454775
Phone : 0729 2292 374 Email : investors@questlabltd.com www.questlabltd.com

Offer Related Information

Initial public offer of 44,49,600 equity shares of face value of Rs. 10/- each (the "Equity Shares") of Quest Laboratories Limited ("The Company" or "Quest" or "The Issuer") for cash at a price of Rs. 97/- per equity share including a share premium of Rs. 87/- per equity share (the "Issue Price") aggregating to Rs. 43.16 crores ("The Issue"), of which 2,28,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 97/- per equity share including a share premium of Rs. 87/- per... More

Take your research to the next level.
Login now to unlock Exclusive Features!

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: